Jin Gohda
Tokyo, 1088639, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A chimeric RNA consisting of siRNA and aptamer for inhibiting dengue virus replication.
Journal: NAR molecular medicine
Published: July 06, 2024
In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases.
Journal: Viruses
Published: March 09, 2023
Reactive oxygen species are associated with the inhibitory effect of N-(4-hydroxyphenyl)-retinamide on the entry of the severe acute respiratory syndrome-coronavirus 2.
Journal: Journal of biochemistry
Published: October 15, 2022
Development of chimeric receptor activator of nuclear factor-kappa B with glutathione S-transferase in the extracellular domain: Artificial switch in a membrane receptor.
Journal: Chemical biology & drug design
Published: September 11, 2021
N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Δ4-Desaturase 1-Independent Mechanism.
Journal: Journal of virology
Published: June 09, 2021
Identification and characterization of Stathmin 1 as a host factor involved in HIV-1 latency.
Journal: Biochemical and biophysical research communications
Published: May 26, 2021
TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-κB activation.
Journal: Proceedings of the Japan Academy. Series B, Physical and biological sciences
Published: April 12, 2021
Discovery of New Potent anti-MERS CoV Fusion Inhibitors.
Journal: Frontiers in pharmacology
Published: March 24, 2021
Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit.
Journal: Biomolecules & therapeutics
Published: November 06, 2020
Last Updated: 09/26/2026